Immunocore Holdings plc (IMCR)

Immunocore Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-35.51	-51.09	-55.29	-52.54	-180.03
Depreciation & Amortization	3.27	4.2	4.09	5.34	7.59
Loss (Gain) From Sale of Investments	-19.73	-14.58	-	-	-
Stock-Based Compensation	37.7	34.19	32.47	32.89	48.89
Other Operating Activities	12.87	4.38	10.04	-10.72	2.4
Change in Accounts Receivable	-7.34	-12.35	-17.87	-26.26	-4.86
Change in Accounts Payable	-2.46	7.27	2.63	4.91	1.47
Change in Unearned Revenue	-0.39	-0	-8.01	-25.5	-29.07
Change in Other Net Operating Assets	0.88	54.03	34.88	22.69	10.5
Operating Cash Flow	-10.71	26.06	2.94	-49.21	-143.11
Operating Cash Flow Growth	-	786.43%	-	-	-
Capital Expenditures	-4.34	-5.17	-5.43	-2.2	-1.39
Sale of Property, Plant & Equipment	-	0.04	-	0.01	0.11
Investment in Securities	-12	-350	-	-	-
Investing Cash Flow	-16.34	-355.13	-5.43	-2.2	-1.28
Long-Term Debt Issued	-	402.5	-	50	-
Long-Term Debt Repaid	-	-52.06	-	-52	-
Net Debt Issued (Repaid)	-	350.44	-	-2	-
Issuance of Common Stock	12.37	6.8	34.35	149.21	288.19
Other Financing Activities	-	-13.36	-	-1.77	-
Financing Cash Flow	12.37	343.88	34.35	145.44	288.19
Foreign Exchange Rate Adjustments	26.66	-1.71	8.29	-12.65	0.63
Net Cash Flow	11.98	13.11	40.15	81.39	144.42
Free Cash Flow	-15.05	20.89	-2.49	-51.41	-144.49
Free Cash Flow Margin	-3.76%	6.73%	-1.00%	-29.49%	-396.04%
Free Cash Flow Per Share	-0.30	0.42	-0.05	-1.13	-3.40
Cash Income Tax Paid	4.64	0.51	0.98	0.77	-17.04
Levered Free Cash Flow	23.96	38.39	14.06	-19.73	-50.31
Unlevered Free Cash Flow	31.56	50.17	17.28	-16.35	-46.83
Change in Working Capital	-9.3	48.95	11.63	-24.17	-21.96

Updated Feb 25, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q